Nuclear Medicine: Page 169

Positron signs supply deal with iThemba

By AuntMinnie.com staff writers

PET vendor Positron has entered into a multiyear radioisotope supply agreement with iThemba Labs of Cape Town, South Africa.

July 30, 2013

Report: U.S. SPECT, PET market looks promising in coming years

By Wayne Forrest

Powered by a number of new products and the potential of novel imaging agents currently in the pipeline, U.S. sales of SPECT and PET radiopharmaceuticals and scanners could top the billion-dollar mark by the next decade, according to a new market research report from Bio-Tech Systems.

July 29, 2013

SNMMI urges support for beta-amyloid PET

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is encouraging its members to send comments to the U.S. Centers for Medicare and Medicaid Services in support of beta-amyloid PET imaging before the August 2 public comment deadline.

July 25, 2013

Naviscan touts clinical study results

By AuntMinnie.com staff writers

PET developer Naviscan is highlighting clinical trial results that show positron emission mammography (PEM) imaging with a breast-cancer-specific tracer achieved 100% sensitivity.

July 24, 2013

Misdiagnosis of Alzheimer's can cost big money

By Wayne Forrest

Receiving a misdiagnosis of Alzheimer's disease can result in tens of thousands of dollars in unnecessary medical costs for patients who actually have vascular dementia or Parkinson's disease, according to a study presented on July 17 at the Alzheimer's Association International Conference in Boston.

July 22, 2013

NOPR leaves legacy of cancer coverage and cooperation

By Wayne Forrest

The seven-year initiative known as the National Oncologic PET Registry (NOPR) began to wind down its operation after the U.S. Centers for Medicare and Medicaid Services announced last month it would halt the data collection requirement for all oncologic indications for FDG-PET as a condition of reimbursement.

July 22, 2013